The authors thank Tongalp Tezel, MD, for consultation regarding sT injection; Theresa Swayne, PhD, for consultation regarding SHG microscopy; and Jimmy Duong from the Design and Biostatistics Resource and the Biostatistical core facility of the Irving Institute at Columbia University Medical Center.
Supported in part by Research to Prevent Blindness and by National Institutes of Health Grants NCRR UL1RR024156, NEI P30 EY019007, NCI P30 CA013696, and NEI R01EY020495 (DCP). Columbia University owns related intellectual property: US issued patents no: 8,466,203 and no: 9,125,856. International patent pending: PCT/US2015/020276.
Images were collected in the Confocal and Specialized Microscopy Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University, supported by NIH grant #P30 CA013696 (National Cancer Institute). The confocal microscope was purchased with NIH grant #S10 RR025686.

All procedures were performed using cadaveric rabbit eyes within intact outbred rabbit heads. All Institutional and National guidelines for the care and use of laboratory animals were followed.
1. Preparation of Solutions
<ol>
	<li>SMG preparation for TXL:
	<ol>
		<li>Prepare 1 mL of 0.2 M concentration of sodium bicarbonate solution (NaHCO3) solution using 0.0165g of NaHCO3 powder dissolved in 1 mL of the distilled water.</li>
		<li>Dissolve 0.1016 mg of powdered sodium hydroxymethylglycinate (SMG) in 1 mL of the distilled water to get a final concentration of 800 mM SMG. Adjust sodium bicarbonate solution to a final concentration of 0.1 M NaHCO3 and 400 mM SMG. Concentrations of SMG depending on the cross-linking effect desired. In the protocol described here we used 40, 100, and 400 mM SMG.</li>
	</ol>
	</li>
</ol>
2. SubTenon&#39;s Injection for TXL using SMG
<ol>
	<li>Fill two 1 mL insulin syringes (25G needles) with 400 &#181;L control and SMG solution, respectively.</li>
	<li>Place the rabbit&#39;s head in a profile plane with the help of a cushion. Styrofoam or a paper stack can be used to fix the head in an optimal position.</li>
	<li>Retract the eyelids with a pediatric eye speculum.</li>
	<li>Measure the initial intraocular pressure (IOP) using an applanation tonometry device.</li>
	<li>Mark the site of intended injection on the upper middle part of the limbus with a tissue marker.</li>
	<li>Retract the conjunctiva surrounding the site of injection with a conjunctival forceps (or any forceps with serrated round tip) and insert the needle through the conjunctiva, entering Tenon&#39;s capsule just slightly beyond the marked limbal site (i.e., 2-3 mm from the limbus). A small incision in the conjunctiva can also be made with iris scissors in order to facilitate the passage of the needle through Tenon&#39;s capsule.</li>
	<li>Once within Tenon&#39;s capsule, make sure that the needle is freely mobile by moving it side-to-side. During this time, the globe should not move. This confirms proper placement of the needle above the sclera in the sub-Tenon&#39;s (sT) space.</li>
	<li>Inject the solution from the syringe and discard the needle. Immediately following injection, the fluid will accumulate in the sT space creating an anterior bulge seen through the conjunctiva (i.e., chemosis).</li>
	<li>Repeat the IOP measurement in order to confirm that it did not change due to an inadvertent perforation of the globe.</li>
	<li>Remove the lid speculum, and perform digital massage through the closed eyelids for about 2-3 min.</li>
	<li>Leave the head for an incubation period of 3.5 h (room temperature = 18 &#176;C), prior to moving to the next step.</li>
</ol>
3. Tissue Preparation
<ol>
	<li>Retract the eyelids using the eyelid speculum in order to optimize access to the globe. Select the optimally sized speculum according to the size of the eye.</li>
	<li>Separate the conjunctiva surrounding the limbus. If it has already been incised near the site of injection, circumferentially expand the borders so it would contain an inoculum size of approximately 1x1 cm.</li>
	<li>Cut the extra-ocular muscles at their sites of scleral insertion.</li>
	<li>Elevate the eyeball with forceps, pushing it from the posterior side. This provides access to the posterior globe and will facilitate cutting of the optic nerve with ophthalmic artery and vein located near the posterior pole of the globe.</li>
	<li>Cut out the corneoscleral complex, with the outer border including the marked injection site. The stain should still be visible on the remaining part of the sclera.</li>
	<li>Remove the corpus vitreus and all layers attached to the inner side of the sclera by applying traction with tissue forceps. 
	NOTE: Further steps depend on the following procedures being performed: 4.-DSC analysis, 5.-SHG microscopy.</li>
</ol>
4. For Regional DSC Analysis
<ol>
	<li>For the treated eye: cut out four scleral sectors from the remaining scleral cup with the scissors so that the site of the injection is located in the upper sector and aligned centrally. Cut the remaining 3 sectors from both lateral sides (i.e., nasal and temporal), and the bottom. 
	NOTE: the numbering of the sectors (1-4) which are further divided into squares (1-16) is demonstrated in Figure 1A.</li>
	<li>Cut the scleral sectors (1-4) into smaller squares (1-16) of approximately 4 x 4 mm each. Sector 1 should be divided into 9 squares (make the exact site of injection an individual square [square 2]). Divide sectors 2 and 3 into 2 squares each (squares 10-11 and 12-13) and sector 4 into 3 squares (squares 14-16).</li>
	<li>Assign a number to each square, as shown in Figure 1A, in order to localize the distance of the analyzed tissue from the location of the injected area.</li>
	<li>For the control eye: after dividing the tissue into four scleral sectors (similar to the treated tissue) cut out square pieces of tissue from the following locations: 3 squares from the top sector (sector 1), 1 from each side (sectors 2 and 3), and 1 from the bottom sector (sector 4).</li>
	<li>Scrape off the remaining retinal and choroidal layers and wash twice with fresh PBS each time, leaving the pieces submerged in solution for approximately 10 s at a time.</li>
</ol>
5. For SHG Imaging
<ol>
	<li>Cut the upper part of the sclera using scissors to create a 1&#160;x 1&#160;cm area with the site of injection aligned centrally.</li>
	<li>Scrape off the remaining retinal and choroid layers and wash twice with fresh PBS each time leaving the pieces in solution for approximately 10 s.</li>
	<li>Place the tissue in 1 mL tubes filled with PBS solution for transportation to the imaging facility. All the procedures, following the incubation time and beginning with the dissection of the eyeball should be performed within an hour.</li>
</ol>
6. Microscopy Protocol
NOTE: This protocol for imaging back-scattered SHG signal from collagen of sclera tissue is tailored for the laser scanning microscope.
<ol>
	<li>Microscopy set up
	<ol>
		<li>To maximize the signal and resolution when performing SHG microscopy use an objective lens optimize to transmit infrared light and with a high numerical aperture (NA). Our objective is Nikon Apo LWD 25x/NA1.1 water immersion.</li>
		<li>Adjust the correction collar of the lens to match the depth of the sample, in this case that is the thickness of the coverslip, 0.17 millimeters.</li>
		<li>Mount the 25x objective lens and add a generous amount of lubricating water-based gel to cover the imaging surface before mounting the sample. The water-based gel will not evaporate during the experiment and hence will maintain image quality.</li>
		<li>Place the scleral tissue from a 1 mL tube with PBS without drying between two 25-mm round coverslips (episcleral side down) providing maximal contact between the episclera and the coverslip surface. 
		NOTE: The tissue can also be placed uncovered on the coverslip. A good amount of PBS should keep the tissue hydrated during imaging. In this case, add the tissue piece and the PBS after assembling the cellchamber.</li>
		<li>Assemble the cell chamber by placing a 25-mm round coverslip, single or in a sandwich technique, on the bottom part of the chamber and screw the top part down in order to create a sealed round chamber. Do not screw down tightly when a top coverslip is used, in order to avoid artificially flattening and damage the tissue.</li>
		<li>Mount the cell chamber with the tissue sample on the microscope stage.</li>
		<li>Set the microscope for eye view with transmitted light on.</li>
		<li>Position the stage and adjust the height of the objective such that the lower surface of the sample is in focus, as determined by bright field inspection through the eye piece.</li>
		<li>Turn off all lights except the computer monitor and block as much light from the monitor as possible with aluminum foil sheets draped on the microscope stage. Minimizing any stray light reaching the detectors will ensure low-noise acquisition, as the GaAsP NDD detectors have high sensitivity.</li>
		<li>In the Ti Pad panel of the software, check that the lens definition is correct.</li>
		<li>In the A1 Compact GUI panel, choose the IR laser for imaging, select the NDD detectors and choose the DAPI channel that is equipped with a 400-450 nm bandpass filter.</li>
		<li>In the A1 MP GUI panel, set the wavelength of the infrared laser to 860 nm and open the shutter.</li>
		<li>Set laser scanning conditions in the A1 Compact GUI panel as follows. Select: (a) Galvano scanner, (b) Unidirectional scanning, (c) Pixel dwell time 6.2 &#181;s, (d) Frame size 1,024 x 1,024 pixels, (e) Line averaging 2x 
		NOTE: The Galvano scanner and unidirectional scanning ensures precise point by point alignment. A size of 1,024 x 1,024 for the full field of view translates into a pixel size of 0.5 &#956;m /pixel. Line averaging will reduce the shot noise in the image.</li>
		<li>Set imaging conditions in A1 Compact GUI panel by adjusting laser power and detector gain. Open the Look Up Table panel (LUTs) that displays a histogram of pixel intensity values in the current image. Turn on live imaging in &#8220;Find&#8221; mode and maximize the detected range of pixel values by adjusting laser power and detector gain. Avoid saturation. Typical values are 2.5% laser power, from a total of 2.35 W at 860 nm, and 100 HV (detector gain).</li>
		<li>NOTE: For this setup, the laser power measured with an internal power meter is 5.2 mW. Every time an experiment is performed, re-adjust the laser percentage such that the internal power measurement is constant at 5.2 mW between imaging sessions. Care should be taken when setting laser power. The Chameleon II laser is a 3 W laser at 800 nm and a 10% or higher power could potentially induce tissue damage.</li>
	</ol>
	</li>
	<li>Image acquisition
	<ol>
		<li>In preview mode, scan the tissue area using the XYZ Overview tool.</li>
		<li>Set the imaging to lower resolution (256 x 256 pixels and no line averaging) to speed up the acquisition of images in this mode.</li>
		<li>Capture 5 x 5, 3 x 3, or single fields of view to cover the entire surface of the tissue. At each location, before the overview capture, turn on the live &#34;Scan&#34; mode and bring the tissue into focus. Note that different regions of the tissue will have slightly different positions in the axial direction.</li>
		<li>Find a flat area where the collagen fibers are seen in the entire field of view and double-click that position in the overview tool to move the stage to that particular location.</li>
		<li>Turn on live &#34;Scan&#34; mode, adjust the Z position of the objective such that the bottom plane is in focus and, in the Ti Pad, use the Z drive to move the optical plane 10-15 &#956;m above this bottom layer.</li>
		<li>Acquire an image at high resolution with 1,024 x 1,024 pixels and 2x line averaging, using the &#34;Capture&#34; button.</li>
		<li>Save the location in the XYZ Overview using the &#34;+&#34; button. This ensures that the same area of tissue is not recaptured.</li>
		<li>For each piece of tissue capture 10 images of non-overlapping fields of view.</li>
	</ol>
	</li>
</ol>
7. DSC Protocol
Note:&#160;Proceed to this step as soon as tissue preparation is complete, for regional DSC analysis, or after tissue imaging when SHGM is performed.
<ol>
	<li>Prepare DSC pans, weighed and labeled. 
	NOTE: This step should be done before tissue dissection in order to minimize tissue desiccation.</li>
	<li>Dry each scleral square with an absorbent tissue and lay it flat on the bottom of a DSC pan using toothed forceps.</li>
	<li>Weigh the pan with the tissue inside and lid crimped and covered to obtain the tissue wet weight (mass of the samples should be in the range of 5 to 11 mg). 
	Note: Seal each pan using the crimper before proceeding to the next tissue sample. The pans are hermetically sealed, preventing any water loss prior to thermal analysis.</li>
	<li>Once the sample is crimped, place it on its designated location on the DSC tray. There should be 6 samples for the control and 16 for the treated eye.</li>
	<li>Create a method using instrument managing software, specifying the weight of the tissue, and run the thermal analysis using the following parameters: Temperature range of 40 to 80 &#176;C, Heating rate: 1 &#176;C/min, Heat flow: 17.37 mW, Gas (N2) flow: 19.8 mL/min, Gas pressure: 2.2 bar.</li>
	<li>Once completed, analyze the data for each sample by extracting the transition temperature peak at which thermal denaturation occurs using the instrument managing software.</li>
</ol>
8. Image Analysis
<ol>
	<li>SHG Signal
	<ol>
		<li>Select at least 5-10 of the most representative images from each treatment and its control, such that the area of the image is occupied by mostly collagen fibers.</li>
		<li>Upload each image in ImageJ software and measure the average pixel intensity by selecting Analyze&#62; Measure for the active image.</li>
		<li>The values extracted are reported as the mean pixel intensity and can also be shown by plotting the histogram of intensities by selecting from the menu Analyze &#62; Histogram.</li>
		<li>Using an Excel sheet, create a table to document all measured data accordingly to the sample ID.</li>
		<li>Calculate the mean and standard deviation of pixel intensity for each treatment and control condition.</li>
		<li>Using student&#39;s t-test, compare differences for all pairwise comparisons of concentrations (i.e., 40 mM SMG vs. 0 and 400 mM SMG vs. 0). [P&#8804;0.05].</li>
	</ol>
	</li>
	<li>Waviness
	<ol>
		<li>Select an image that displays collagen fibers. At least 10 images per sample should be analyzed (including a control sample for each concentration - at least 40 in total).</li>
		<li>Open ImageJ&#62;Plugins&#62; NeuronJ. NeuronJ requires prior installation.</li>
		<li>Upload all imagesby dragging into an opened NeuronJ window.</li>
		<li>Create tracing lines along the fibers, following the contour of the fibril with the mouse (pen drawing tablets could be used), click M to measure the distance of total fiber length.</li>
		<li>Select &#34;Option&#34; to draw a tangential straight line and connect the beginning and the end of the previously drawn fiber contour. Now click M to measure the end-to-end length.</li>
		<li>Repeat the same procedure on at least 10 fibrils per image.</li>
		<li>Collect those two measurements from each of 10 fibrils and input the data into an excel spreadsheet, expressing total fiber length (contour) and end-to-end length (straight connecting line) as Length [curve] and Length [linear], respectively.</li>
		<li>Calculate the waviness index (W) using the formula: W= Length [curve]/ Length [linear].</li>
		<li>Calculate the % of waviness comparing data from the images of treated samples(SMG) with the images from control samples using the formula: (W[SMG] - 1) / ( W[control] - 1 )</li>
		<li>Perform a pairwise t-test for waviness index (W) in order to determine statistical differences (p-values) of collagen fiber morphology between different treatment conditions and control.</li>
	</ol>
	</li>
</ol>

The authors have nothing to disclose.

Conducted experiments have shown evidence supporting the use of SHG signal microscopy as a method for evaluation of collagen cross-linking effects in sclera, raising the future possibility of using this technique as a monitoring tool for cross-linking treatments that target collagen proteins. Of note, an instrument already is in clinical use that can potentially capture this SHG signal. Although this instrument was primarily designed for imaging skin human dermis, it has been used successfully to image cornea and sclera<...

Progressive myopia is postulated to be treatable through non-enzymatic scleral cross-linking (photochemical and/or chemical), which makes sense given that blocking collagen enzymatic cross-linking can increase experimental form deprivation (FD)-induced myopia1. Elsheikh and Phillips2 recently discussed the feasibility and potential of using standard ultraviolet-A irradiation (UVA)-riboflavin mediated photochemical cross-linking (also known as the Dresden protocol), abbreviated here as (riboflavin CXL) for posterior scleral stabilization to halt axial elongation in myopia. This photochemical method has been successfully used for treating destabilization of the anterior globe surface (i.e., the bulging cornea) seen in keratoconus and post-LASIK keratectasia. However, application of this CXL protocol for the sclera is hindered by issues related to difficulties in accessing the posterior sclera with an ultraviolet (UV) light source, as well as the need to modify a much greater tissue surface area. That being said, the CXL approach has been used to halt axial elongation in visually form deprived rabbits (by tarsorrhaphy), although multiple regions of posterior sclera required multiple separate irradiation zones in that study3. By contrast, injection of a chemical stabilizing agent (i.e., cross-linking agent) via the sT space could represent a simpler way to modify the posterior sclera, avoiding the need for introducing a UV light source. This injection technique is well known as a useful way of inducing ocular anesthesia during ophthalmologic procedures such as cataract surgery4,5,6. Wollensak7 has described previously the use of an sT injection using glyceraldehyde (a chemical cross-linking agent similar in concept to the formaldehyde releasing agents (FARs) described in this study) to stiffen the rabbit sclera and genipin has been shown to limit axial length in FD guinea pigs8,9. These investigators have demonstrated a clear advantage of using a soluble chemical agent over the photochemical CXL technique. Thus, scleral cross-linking using an injectable chemical agent of some type, including the FARs (i.e., TXL)10, could provide a feasible treatment method to halt the progression of scleral elongation seen in myopia.
In the protocols presented here, we use a chemical cross-linking solution of sodium hydroxymethylglycinate (SMG), delivered via sT injection to the sclera of cadaveric rabbit eyes. We have implemented similar protocols previously for topical chemical cross-linking in the cornea. Notably in those previously reported studies, concentration dependent cross-linking effects could be obtained using SMG, with an effect range spanning well above that achievable with photochemical CXL as determined by thermal denaturation analysis11.
Here we describe protocols to assess the cross-linking effect of SMG delivered via sT injections to scleral tissue, thermal denaturation using Differential Scanning Calorimetry (DSC), and Second Harmonic Generation Microscopy (SHGM).
Using differential scanning calorimetry (DSC), also known as thermal analysis, a thermal denaturation transition is measured, which for scleral tissue is predominately guided by the properties of the fibrillar collagens, since they constitute the bulk majority of protein. This method evaluates the stability of collagen molecular structure and the cross-linked bonds that stabilize the collagen fibrils, the principal tertiary protein structure. During heating in the DSC, a critical transition temperature is achieved that results in denaturation of the collagen molecule, resulting in uncoiling of the triple helix, a process that forms what is commonly known as gelatin. This thermal denaturation disrupts hydrogen bonds along the collagen molecule and can be shifted to higher temperatures through induced cross-linking methods12,13. This method has been used for many decades, particularly in the biomaterials industry and for processes that include leather-making. However, this method requires extraction of the sclera tissue and therefore can only be useful as an ex vivo technique.
Second-harmonic generation microscopy (SHGM) is based on the non-linear optical properties of particular materials, with non-centrosymmetric molecular environments. In such materials, intense light, for example light produced by lasers, generates SHG signals, in which the incident light is doubled in frequency. Biological materials that are known to create SHG signals are collagen, microtubules, and muscle myosin. For example, collagen excited with an infrared light of 860 nm wavelength will emit an SHG signal in the visible range with 430 nm wavelength. Second harmonic generation (SHG) signal imaging is a promising method for evaluating therapeutic collagen cross-linking. It has been known for more than 30 years that collagen fibrils in tissues emit SHG signals14. However, only recently could high resolution images be obtained15 in a variety of tissues, including tendon16, skin, cartilage17, blood vessels18, and in collagen gels19.
Based on this knowledge, this study evaluates the SHG signal changes induced in the sclera through SMG chemically induced cross-linking of collagen. The results indicate that SMG modification of the sclera increases the SHG signals produced from tissue collagen fiber bundles (the higher order quaternary structure comprised of collagen fibrils) and also produces a structural morphologic change in the collagen fiber network, reflected in fiber bundle &#34;straightening.&#34;

<table><tbody><tr><td>MILLI-Q SYNTHESIS A10 120V</td><td>EMD Millipore, Massachusetts, USA</td><td></td><td>Double distilled, deionized water. - protocol step 1.1.1</td></tr><tr><td>Sodium hydroxymethylglycinate&amp;nbsp;</td><td>Tyger Chemicals Scientific, Inc. Ewing, NJ, USA</td><td></td><td>Crosslinking reagent - protocol step 1.1.2</td></tr><tr><td>Injection needle with luer-lock syringe</td><td>BD Eclipse, NJ, USA</td><td></td><td>Syringe for sub tenon injection. - protocol step 2.1</td></tr><tr><td>Rabbit head</td><td>La Granja poultry</td><td>Outbred</td><td>Rabbit head separated and delivered within 1 hour postmortem. - protocol step 2.2</td></tr><tr><td>Tono-pen&amp;nbsp;</td><td>Reichter Technologies Depew, NY</td><td></td><td>IOP measurements - protocol step 2.4</td></tr><tr><td>DSC 6000 Autosampler</td><td>Perkin-Elmer Waltham, MA, USA</td><td></td><td>Thermal denaturation analyzer - protocol step 7.4</td></tr><tr><td>Pyris software&amp;nbsp;</td><td>Perkin-Elmer, Waltham, MA, USA</td><td>Ver 11.0</td><td>&amp;nbsp;protocol step 7.5</td></tr><tr><td>CFI75 Apochromat LWD 25X/1.10 W MP</td><td>Nikon Instruments, Melville, NY, USA</td><td></td><td>A water immersionn objective with high IR transmittance with a working distance of 2.0 mm - protocol step 8.1.1.</td></tr><tr><td>GenTeal&amp;nbsp;</td><td>Alcon, Fort Worth, TX&amp;nbsp;</td><td>B000URVDQ8</td><td>Water-based gel used as objective immersion medium instead of water to prevent evaporation - 8.1.1</td></tr><tr><td>Chameleon Vision II&amp;nbsp;</td><td>Coherent, Santa Clara,CA, USA</td><td></td><td>Ti:Sapphire pulsed laser with a 140 fs pulse width at 80 MHz and a tunable range from 680 nm to 1080 nm. - protocol step 8.1.11</td></tr><tr><td>AttoFluor cell chamber</td><td>Thermo Fisher Scientific Inc</td><td>A7816</td><td>Fixation of the cover slip - protocol step 8.1.3</td></tr><tr><td>25-mm round coverslips, #1.5</td><td>Neuvitro Corporation, Vancouver, WA, USA</td><td>GG-25-1.5</td><td>protocol step 8.1.3</td></tr><tr><td>Eclipse Ti-E</td><td>Nikon Instruments, Melville, NY, USA</td><td></td><td>protocol step 8.1.4.</td></tr><tr><td>Non-descanned (NDD) GaAsP detector</td><td>Nikon Instruments, Melville, NY, USA</td><td></td><td>Equipped with a 400-450 nm band pass filter - protocol step 8.1.7</td></tr><tr><td>A1R-MP laser scanning system</td><td>Nikon Instruments, Melville, NY, USA</td><td></td><td>Compatible with infrared (IR) multi-photon excitation. - protocol step 8.1.8</td></tr><tr><td>NIS Elements software</td><td>Nikon Instruments, Melville, NY, USA</td><td>Ver 4.3</td><td>refered to as &quot;software&quot; in the text - protocol step 8.1.9</td></tr><tr><td>Fiji/ImageJ</td><td>National Institute of Health</td><td></td><td>&amp;nbsp;protocol step 9.1.2</td></tr><tr><td>NeuronJ</td><td>Eric Meijering, Erasmus University Medical Center, Rotterdam, The Netherlands</td><td></td><td>https://imagescience.org/meijering/software/neuronj/, for protocol step 9.2.2</td></tr><tr><td>Microsoft Excel&amp;nbsp;</td><td>Microsoft Corporation, Redmond, WA, USA</td><td>Ver 14</td><td>protocol step 9.2.8</td></tr></tbody></table>

second harmonic generation signals in rabbit sclera as a tool for evaluation of therapeutic tissue cross-linking (txl) for myopia

Methods to strengthen tissue by introducing chemical bonds (non-enzymatic cross-linking) into structural proteins (fibrillar collagens) for therapy include photochemical cross-linking and tissue cross-linking (TXL) methods. Such methods for inducing mechanical tissue property changes are being employed to the cornea in corneal thinning (mechanically weakened) disorders such as keratoconus as well as the sclera in progressive myopia, where thinning and weakening of the posterior sclera occurs and likely contributes to axial elongation. The primary target proteins for such tissue strengthening are fibrillar collagens which constitute the great majority of dry weight proteins in the cornea and sclera. Fortuitously, fibrillar collagens are the main source of second harmonic generation signals in the tissue extracellular space. Therefore, modifications of the collagen proteins, such as those induced through cross-linking therapies, could potentially be detected and quantitated through the use of second harmonic generation microscopy (SHGM). Monitoring SHGM signals through the use of a laser scanning microscopy system coupled with an infrared excitation light source is an exciting modern imaging method that is enjoying widespread usage in the biomedical sciences. Thus, the present study was undertaken in order to evaluate the use of SHGM microscopy as a means to measure induced cross-linking effects in ex vivo rabbit sclera, following an injection of a chemical cross-linking agent into the sub-Tenon&#39;s space (sT), an injection approach that is standard practice for causing ocular anesthesia during ophthalmologic clinical procedures. The chemical cross-linking agent, sodium hydroxymethylglycinate (SMG), is from a class of cosmetic preservatives known as formaldehyde releasing agents (FARs). Scleral changes following reaction with SMG resulted in increases in SHG signals and correlated with shifts in thermal denaturation temperature, a standard method for evaluating induced tissue cross-linking effects.

Thermal denaturation temperature (Tm) as an assay method to evaluate TXL cross-linking effect: A total of 16 pairs of rabbit eyes were used in these experiments for the TXL procedure.As an initial part of this study, the localization of cross-linking effect induced by a single injection of SMG cross-linking agent via sT space in the cadaveric rabbit head was evaluated. This type of experiment has relevance to the clinical treatment of patients, since injections in more th...

Watch this Scientific Journal Video about Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia at JoVE.com

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

This protocol describes techniques for evaluating chemical cross-linking of the rabbit sclera using&#160;second harmonic generation imaging and differential scanning calorimetry.

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Methods to strengthen tissue by introducing chemical bonds (non-enzymatic cross-linking) into structural proteins (fibrillar collagens) for therapy ...

second-harmonic-generation-signals-rabbit-sclera-as-tool-for

Research

JoVE Journal

Medicine

7.7K Views.  Columbia University College of Physicians and Surgeons. Dit protocol beschrijft technieken voor de beoordeling van de chemische cross-linking van het konijn sclera met behulp van tweede-harmonische generatie beeldvorming en differentiële scanning calorimetrie.

Video: Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes

Photoacoustic ocular imaging is an emerging ophthalmic imaging technology that can noninvasively visualize ocular tissue by converting light energy into sound waves and is currently under intensive investigation. However, most reported work to date is focused on the imaging of the posterior segment of the eyes of small animals, such as rats and mice, which poses challenges for clinical human translation due to small eyeball sizes. This manuscript describes a novel photoacoustic microscopy (PAM) and optical coherence tomography (OCT) dual-modality system for posterior segment imaging of the eyes of larger animals, such as rabbits. The system configuration, system alignment, animal preparation, and dual-modality experimental protocols for in vivo, noninvasive, label-free chorioretinal imaging in rabbits are detailed. The effectiveness of the method is demonstrated through representative experimental results, including retinal and choroidal vasculature obtained by the PAM and OCT. This manuscript provides a practical guide to reproducing the imaging results in rabbits and advancing photoacoustic ocular imaging in larger animals.

This manuscript describes the novel setup and operating procedure of a photoacoustic microscopy and optical coherence tomography dual-modality system for noninvasive, label-free chorioretinal imaging of larger animals, such as rabbits.

Photoacoustic ocular imaging is an emerging ophthalmic imaging technology that can noninvasively visualize ocular tissue by converting light energy into ...

Engineering

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Keratoconus is a bilateral and progressive corneal ectasia. In order to slow down its progression, corneal collagen cross-linking (CXL) has recently been introduced as an efficient treatment option. In biological and chemical sciences, crosslinking refers to new chemical bonds formed between reactive molecules. Hence, the aim of corneal collagen CXL is to synthetically increase the formation of crosslinks between collagen fibrils in the corneal stroma. Despite the fact that the efficiency of the conventional CXL (C-CXL) protocol has already been shown in several clinical studies, it might benefit from improvements in duration of the procedure and removal of corneal epithelium. Hence, in order to provide a coherent evaluation of two new and optimized CXL protocols, we studied keratoconus patients who had undergone one of the three CXL treatments: iontophoresis (I-CXL), accelerated CXL (A-CXL), and conventional CXL (C-CXL). A-CXL is a 6 time faster CXL procedure using a ten time higher UVA irradiance but still including an epithelium removal. Iontophoresis is a transepithelial non-invasive technique in which a small electric current is applied to improve riboflavin penetration throughout the cornea. Using anterior segment optical coherence tomography (AS OCT) and in vivo confocal microscopy (IVCM), we conclude that regarding the depth of treatment penetration, conventional CXL protocol remains the standard for treating progressive keratoconus. Accelerated CXL seems to be a quick, effective and safe alternative to treat thin corneas. The use of iontophoresis is still being investigated and should be considered with greater caution.

Corneal collagen cross-linking (CXL) is the only conservative treatment currently available to halt keratoconus progression by improving the biomechanical rigidity of the corneal stroma. The aim of this manuscript is to highlight the methods of three different protocols of CXL: conventional CXL (C-CXL), accelerated CXL (A-CXL), and iontophoresis CXL (I-CXL).

Keratoconus is a bilateral and progressive corneal ectasia. In order to slow down its progression, corneal collagen cross-linking (CXL) has recently been ...

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Myopic individuals, especially those with severe myopia, are at higher-than-normal risk of cataract, glaucoma, retinal detachment and chorioretinal abnormalities. In addition, pathological myopia is a common irreversible cause of visual impairment and blindness1-3. Our study demonstrates the effect of scleral crosslinking using riboflavin and ultraviolet-A radiation on the development of axial myopia in a rabbit model. The axial length of the eyeball was measured by A-scan ultrasound in New Zealand white rabbits aged 13 days (male and female). The eye then underwent 360&#176; conjunctival peritomy with scleral crosslinking, followed by tarsorrhaphy. Axial elongation was induced in 13 day-old New Zealand rabbits by suturing their right eye eyelids (tarsorrhaphy). The eyes were divided into quadrants, and every quadrant had two scleral irradiation zones, each with an area of 0.2 cm&#178; and a radius of 4 mm. Crosslinking was performed by dropping 0.1% dextran-free riboflavin-5-phosphate onto the irradiation zones 20 sec before ultraviolet-A irradiation and every 20 sec during the 200 sec irradiation time. UVA radiation (370 nm) was applied perpendicular to the sclera at 57 mW/cm&#178; (total UVA light dose, 57 J/cm&#178;). Tarsorrhaphies were removed on day 55, followed by repeated axial length measurements. This study demonstrates that scleral crosslinking with riboflavin and ultraviolet-A radiation effectively prevents occlusion-induced axial elongation in a rabbit model.

We demonstrate the effect of scleral crosslinking with riboflavin and UVA on an axial elongation rabbit eye. Axial elongation was induced in 13 day-old New Zealand rabbits (male and female) by suturing their right eye eyelids (tarsorrhaphy).

Myopic individuals, especially those with severe myopia, are at higher-than-normal risk of cataract, glaucoma, retinal detachment and chorioretinal ...

A Step by Step Protocol for Subretinal Surgery in Rabbits

Age related macular degeneration (AMD), retinitis pigmentosa, and other RPE related diseases are the most common causes for irreversible loss of vision in adults in industrially developed countries. RPE transplantation appears to be a promising therapy, as it may replace dysfunctional RPE, restore its function, and thereby vision.
Here we describe a method for transplanting a cultured RPE monolayer on a scaffold into the subretinal space (SRS) of rabbits. After vitrectomy xenotransplants were delivered into the SRS using a custom made shooter consisting of a 20-gauge metallic nozzle with a polytetrafluoroethylene (PTFE) coated plunger. The current technique evolved in over 150 rabbit surgeries over 6 years. Post-operative follow-up can be obtained using non-invasive and repetitive in vivo imaging such as spectral domain optical coherence tomography (SD-OCT) followed by perfusion-fixed histology.
The method has well-defined steps for easy learning and high success rate. Rabbits are considered a large eye animal model useful in preclinical studies for clinical translation. In this context rabbits are a cost-efficient and perhaps convenient alternative to other large eye animal models.

Retinal pigment epithelium (RPE) replacement strategies and gene-based therapy are considered for several retinal degenerative conditions. For clinical translation, large eye animal models are required to study surgical techniques applicable in patients. Here we present a rabbit model for subretinal surgery geared towards RPE transplantation, which is versatile and cost-efficient.

Age related macular degeneration (AMD), retinitis pigmentosa, and other RPE related diseases are the most common causes for irreversible loss of vision in ...

In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography

Spectral-domain optical coherence tomography (SD-OCT) is useful for visualizing retinal and ocular structures in vivo. In research, SD-OCT is a valuable tool to evaluate and characterize changes in a variety of retinal and ocular disease and injury models. In light induced retinal degeneration models, SD-OCT can be used to track thinning of the photoreceptor layer over time. In glaucoma models, SD-OCT can be used to monitor decreased retinal nerve fiber layer and total retinal thickness and to observe optic nerve cupping after inducing ocular hypertension. In diabetic rodents, SD-OCT has helped researchers observe decreased total retinal thickness as well as decreased thickness of specific retinal layers, particularly the retinal nerve fiber layer with disease progression. In mouse models of myopia, SD-OCT can be used to evaluate axial parameters, such as axial length changes. Advantages of SD-OCT include in vivo imaging of ocular structures, the ability to quantitatively track changes in ocular dimensions over time, and its rapid scanning speed and high resolution. Here, we detail the methods of SD-OCT and show examples of its use in our laboratory in models of retinal degeneration, glaucoma, diabetic retinopathy, and myopia. Methods include anesthesia, SD-OCT imaging, and processing of the images for thickness measurements.

Here, we describe the use of spectral-domain optical coherence tomography (SD-OCT) to visualize retinal and ocular structures in vivo in models of retinal degeneration, glaucoma, diabetic retinopathy, and myopia.

Spectral-domain optical coherence tomography (SD-OCT) is useful for visualizing retinal and ocular structures in vivo. In research, SD-OCT is a valuable ...

Bioengineering

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

HR-SD-OCT is utilized to monitor the progression of photoreceptor degeneration in live mouse models, assess the delivery of therapeutic agents into the subretinal space, and to evaluate toxicity and efficacy in vivo. HR-SD-OCT uses near infrared light (800-880 nm) and has optics specifically designed for the unique optics of the mouse eye with sub-2-micron axial resolution. Transgenic mouse models of outer retinal (photoreceptor) degeneration and controls were imaged to assess the disease progression. Pulled glass microneedles were used to deliver sub retinal injections of adeno-associated virus (AAV) or nanoparticles (NP) via a trans-scleral and trans-choroidal approach. Careful positioning of the needle into the subretinal space was required prior to a calibrated pressure injection, which delivers fluid into the sub retinal space. Real time subretinal surgery was conducted on our retinal imaging system (RIS). HR-SD-OCT demonstrated progressive uniform retinal degeneration due to expression of a toxic mutant human mutant rhodopsin (P347S) (RHOP347S) transgene in mice. HR-SD-OCT allows rigorous quantification of all the retinal layers. Outer nuclear layer (ONL) thickness and photoreceptor outer segment length (OSL) measurements correlate with photoreceptor vitality, degeneration, or rescue. The RIS delivery system allows real-time visualization of subretinal injections in neonatal (~P10-14) or adult mice, and HR-SD-OCT immediately determines success of delivery and maps areal extent. HR-SD-OCT is a powerful tool that can evaluate the success of subretinal surgery in mice, in addition to measuring vitality of photoreceptors in vivo. HR-SD-OCT can also be used to identify uniform animal cohorts to evaluate the extent of retinal degeneration, toxicity, and therapeutic rescue in preclinical gene therapy research studies.

Here we demonstrate a novel approach to using high resolution spectral-domain optical coherence tomography (HR-SD-OCT) to assist delivery of gene therapy agents into the subretinal space, assess its areal coverage, and characterize photoreceptor vitality.

HR-SD-OCT is utilized to monitor the progression of photoreceptor degeneration in live mouse models, assess the delivery of therapeutic agents into the ...

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

This study is aimed at examining whether a suprachoroidal graft of autologous cells can improve best corrected visual acuity (BCVA) and responses to microperimetry (MY) in eyes affected by dry Age-related Macular Degeneration (AMD) over time through the production and secretion of growth factors (GFs) on surrounding tissue. Patients were randomly assigned to each study group. All patients were diagnosed with dry AMD and with BCVA equal to or greater than 1 logarithm of the minimum angle of resolution (logMAR). A suprachoroidal autologous graft by Limoli Retinal Restoration Technique (LRRT) was carried out on group A, which included 11 eyes from 11 patients. The technique was performed by implanting adipocytes, adipose-derived stem cells obtained from the stromal vascular fraction, and platelets from platelet-rich plasma in the suprachoroidal space. Conversely, group B, including 14 eyes of 14 patients, was used as a control group. For each patient, diagnosis was verified by confocal scanning laser ophthalmoscope and spectral domain-optical coherence tomography (SD-OCT). In group A, BCVA improved by 0.581 to 0.504 at 90 days and to 0.376 logMAR at 180 days (+32.20%) postoperatively. Furthermore, MY test increased by 11.44 dB to 12.59 dB at 180 days. The different cell types grafted behind the choroid were able to ensure constant GF secretion in the choroidal flow. Consequently, the results indicate that visual acuity (VA) in the grafted group can increase more than in the control group after six months.

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

The goal of this study is to assess whether the suprachoroidal graft of adipose-derived stem cells included in the stromal vascular fraction and platelets derived from platelet-rich plasma by the Limoli Retinal Restoration Technique can improve visual acuity and retinal sensitivity responses in eyes affected by dry age-related macular degeneration.

This study is aimed at examining whether a suprachoroidal graft of autologous cells can improve best corrected visual acuity (BCVA) and responses to ...

Inducement and Evaluation of a Murine Model of Experimental Myopia

Murine model of myopia can be a powerful tool for myopia research because of the comparatively easy genetic manipulation. One way to induce myopia in animals is to put clear minus lenses in front of eyes for weeks (lens-induced myopia, LIM). However, extant protocols for inducement and evaluation vary from laboratory to laboratory. Here, we described a highly practical and reproducible method to induce LIM in mice using newly designed eyeglasses. The method fixes the lens stably in front of the mouse eye while allows the lens to be taken off for cleaning or topical drug administration. The phenotype is robust and efficient, and the variance is small. The method described here can be applied to mice right after weaning which extends the possible duration for experiments. We also gave technical advises for achieving reproducible results in refraction and axial length measurements. We hope the step-by-step protocol described here and the detailed article can help researchers perform myopia experiments with myopia more smoothly and make the data comparable across laboratories.

In this protocol, we describe the full process of experimental myopia inducement in mice using newly designed eyeglasses and the technic needed for achieving stable and reproducible results in ocular parameter measurements.

Murine model of myopia can be a powerful tool for myopia research because of the comparatively easy genetic manipulation. One way to induce myopia in ...

Neuroscience

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Glaucoma, the second leading cause of blindness worldwide, is a heterogeneous group of ocular disorders characterized by structural damage to the optic nerve and retinal ganglion cell (RGC) degeneration, resulting in visual dysfunction by interrupting the transmission of visual information from the eye to the brain. Elevated intraocular pressure is the most important risk factor; thus, several models of ocular hypertension have been developed in rodents by either genetic or experimental approaches to investigate the causes and effects of the disease. Among those, some limitations have been reported such as surgical invasiveness, inadequate functional assessment, requirement of extensive training, and highly variable extension of retinal damage. The present work characterizes a simple, low-cost, and efficient method to induce ocular hypertension in rodents, based on low-temperature, full-circle cauterization of the limbal vascular plexus, a major component of aqueous humor drainage. The new model provides a technically easy, noninvasive, and reproducible subacute ocular hypertension, associated with progressive RGC and optic nerve degeneration, and a unique post-operative clinical recovery rate that allows in vivo functional studies by both electrophysiological and behavioral methods.

The goal of this protocol is to characterize a novel model of glaucomatous neurodegeneration based on 360&#176; thermic cauterization of limbal vascular plexus, inducing subacute ocular hypertension.

Glaucoma, the second leading cause of blindness worldwide, is a heterogeneous group of ocular disorders characterized by structural damage to the optic ...

Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy

Geographic atrophy (GA), the late stage of dry age-related macular degeneration is characterized by loss of the retinal pigment epithelial (RPE) layer, which leads to subsequent degeneration of vital retinal structures (e.g., photoreceptors) causing severe vision impairment. Similarly, RPE-loss and decrease in visual acuity is seen in long-term follow up of patients with advanced wet age-related macular degeneration (AMD) receiving intravitreal anti-vascular endothelial growth factor (VEGF) treatment. Therefore, on the one hand, it is fundamental to efficiently derive RPE cells from an unlimited source that could serve as replacement therapy. On the other hand, it is important to assess the behavior and integration of the derived cells in a model of the disease entailing surgical and imaging methods as close as possible to those applied in humans. Here, we provide a detailed protocol based on our previous publications that describes the generation of a preclinical model of GA using the albino rabbit eye, for evaluation of the human embryonic stem cell derived retinal pigment epithelial cells (hESC-RPE) in a clinically relevant setting. Differentiated hESC-RPE are transplanted into naive eyes or eyes with NaIO3-induced GA-like retinal degeneration using a 25 G transvitreal pars plana technique. Evaluation of degenerated and transplanted areas is performed by multimodal high-resolution non-invasive real-time imaging.

Retinal pigment epithelial cells could serve as a cell-replacement therapy for the advanced form of dry age-related macular degeneration. This protocol describes the generation of a large-eyed model of geographic atrophy and the subretinal transplantation of human embryonic stem cell-derived retinal pigment epithelial cells into this model of disease.

Geographic atrophy (GA), the late stage of dry age-related macular degeneration is characterized by loss of the retinal pigment epithelial (RPE) layer, ...

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia

Samenvatting

Meer video's verkennen

Hoofdstukken in deze video